Copyright
©The Author(s) 2018.
World J Diabetes. Nov 15, 2018; 9(11): 199-205
Published online Nov 15, 2018. doi: 10.4239/wjd.v9.i11.199
Published online Nov 15, 2018. doi: 10.4239/wjd.v9.i11.199
System | Clinical effects |
Cardiovascular | Depressed myocardium contractility |
Changes in SVR | |
Acidosis-aided catecholamine release opposes acidosis-mediated vasodilation. | |
Net SVR depends on the sum of both effects | |
Conduction defects and dysrhythmias | |
Impaired response to exogenous vasopressors | |
Pulmonary | Increased work of breathing and respiratory failure |
Compensatory alveolar hyperventilation | |
Dyspnea (Kussmaul’s breathing) | |
Acute decrease in hemoglobin oxygen affinity (Bohr Effect) | |
Temporary: Affinity rises after 36 h due to depletion of RBC 2,3-DPG | |
Renal | Pseudo-hyperkalemia |
Hyperuricemia | |
Hypercalcemia | |
Hematological effect | Impaired coagulation |
Thrombocytopenia | |
Reduced fibrinogen and thrombin formation | |
Impaired clotting factor function | |
Factor Va | |
Factor VIIa | |
Factor VIIa/tissue factor complex | |
Endocrine | Insulin resistance |
Catecholamine, cortisol, PTH and aldosterone stimulation | |
Bone demineralization | |
Protein wasting | |
Free radical formation | |
Musculoskeletal system | Anti-anabolic effect on the bone growth centers in chronic metabolic acidosis |
Muscle fatigue | |
Central nerve system | Cerebral edema |
Depressed sensorium | |
Immune system | Impaired leukocyte function |
Increased susceptibility to infections |
Table 2 Key findings and conclusions regarding the use of sodium bicarbonate in diabetic ketoacidosis
Sodium bicarbonate use in mild to moderate acidemia (pH ≥ 7.0) is associated with |
No benefit in mortality or duration of hospitalization[12] |
Possible transient benefit in reversal of acidosis[12,14,16] |
Delay in resolution of ketosis[18] |
Trend toward worsening of central nervous system acidosis[15] |
Increased need for potassium supplementation[16] |
Worsened tissue hypoxia[19] |
Cerebral edema and prolonged hospitalization in pediatric patients[12] |
Post-treatment metabolic alkalosis |
Sodium bicarbonate use in severe acidemia (pH < 7.0) has not been well-studied |
No improvement in morbidity or mortality in a small, randomized trial[15] |
Routine use of sodium bicarbonate in diabetic ketoacidosis is not supported by the available literature |
Several situations exist in which the use of sodium bicarbonate may be warranted |
Severe acidosis |
Life-threatening hyperkalemia |
Recovery from saline-induced metabolic acidosis |
Table 3 Key findings and conclusions regarding blood gas monitoring in diabetic ketoacidosis
Venous blood is similar to arterial sampling in measuring |
pH[21-25] |
Bicarbonate[21,24] |
Lactate[21] |
Base excess[21] |
Venous blood gas measurement may be used in place of arterial blood for the purposes of stratifying disease severity in diabetic ketoacidosis |
Blood gas measurement does not often change management of diabetic ketoacidosis, especially when routine chemistries (including bicarbonate level) and ketone body identification are available[25] |
Routine use of arterial and/or venous blood gas measurement may not be necessary in the evaluation and management of diabetic ketoacidosis |
Exceptions where blood gas analysis would likely alter management include |
Abnormal baseline serum bicarbonate levels |
Chronic respiratory failure |
Renal tubular acidosis |
Acute respiratory compromise |
Adequacy of respiratory compensation for metabolic acidosis |
Respiratory muscle fatigue and failure |
- Citation: Patel MP, Ahmed A, Gunapalan T, Hesselbacher SE. Use of sodium bicarbonate and blood gas monitoring in diabetic ketoacidosis: A review. World J Diabetes 2018; 9(11): 199-205
- URL: https://www.wjgnet.com/1948-9358/full/v9/i11/199.htm
- DOI: https://dx.doi.org/10.4239/wjd.v9.i11.199